Pediatric ME/CFS: School-Attending and Ambulatory Cases

Children and adolescents with mild to moderate ME/CFS who retain capacity for school attendance—even partial attendance—represent a critical population for early intervention. The substantially better prognosis in pediatric ME/CFS (54–94% improvement or recovery versus \(\leq\) 22% in adults) creates both opportunity and urgency: appropriate early management may preserve the window for recovery, while inappropriate management (particularly graded exercise therapy) risks progression to severe, potentially irreversible disease (Rowe et al. 2017) (Centers for Disease Control and Prevention 2024).

This chapter addresses ambulatory pediatric patients who can attend school at least part-time. For children who are housebound or bedbound, see Chapter Pediatric ME/CFS: Severe and Housebound Cases. For adult mild-moderate management, see Chapter Action Plans for Mild to Moderate Cases.

NoteChapter Roadmap: How to Use This Chapter

For patients: read the early-intervention, school-accommodation, and pacing sections to understand why prompt, appropriate management preserves the window for recovery.

For caregivers: read the school-accommodation framework, pacing, and social-development sections to support an ambulatory child at school and at home, and the medical-management section to coordinate care.

For clinicians: read the subtype assessment, diagnosis-and-assessment, medical-management, and pacing sections to construct an age-appropriate plan, avoiding the graded exercise that risks progression.

For researchers: the early-intervention and long-term-monitoring sections frame the open question of whether timely management can be shown to improve the favourable pediatric prognosis.

1 Contents

• The Early Intervention Imperative
• Subtype Assessment for Ambulatory Pediatric Cases
• Diagnosis and Assessment
• School Accommodation Framework
• Pacing for Children and Adolescents
• Medical Management
• Activity and Exercise
• Social Development Considerations
• Long-Term Management and Monitoring
• Prognosis Communication
• Summary of Key Recommendations

References

Centers for Disease Control and Prevention. 2024. “Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Children and Adolescents: Information for Healthcare Providers.” https://www.cdc.gov/me-cfs/healthcare-providers/pediatric-mecfs.html.

Rowe, Peter C., Rosemary A. Underhill, Kenneth J. Friedman, Alan Gurwitt, Marvin S. Medow, Michael S. Schwartz, Nigel Speight, Julian M. Stewart, Rosamund Vallings, and Katherine S. Rowe. 2017. “Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer.” Frontiers in Pediatrics 5: 121. https://doi.org/10.3389/fped.2017.00121.